Close
CDMO Safety Testing 2026
Novotech

Getinge Selects Anaqua to Provide Single, Centralized IP Management Platform

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

AI-Driven Cold Chains Transforming Pharma Supply Systems

The integration of artificial intelligence into cold chain management is reshaping the pharmaceutical supply landscape. AI-driven cold chains utilize predictive visibility and intelligent thermal control to optimize logistics operations across global networks. By anticipating risks and automating complex decisions, these systems ensure the integrity of temperature-sensitive medications, significantly enhancing the reliability and efficiency of pharmaceutical distribution on a global scale.

Cold Chain Intelligence Enhancing Pharma Logistics Safety

Global pharmaceutical logistics faces unprecedented challenges in maintaining product integrity during transit. Cold chain intelligence offers a sophisticated solution by integrating predictive monitoring and thermal assurance into a connected supply chain. This approach ensures that life-saving medications and vaccines reach their destination without compromising safety or efficacy, marking a significant evolution in healthcare distribution.
- Advertisement -

Anaqua, the leading innovation and intellectual property (IP) management technology provider announced that global medical technology company Getinge has selected Anaquaโ€™s AQX in order to consolidate the management of all its IP assets onto a single, centralized platform.

Founded in Sweden in 1904, Getinge provides hospitals and life science institutions in 133 countries with products and solutions that aim to improve clinical results and optimize workflows.

Anna Maria Lagerqvist Gahm,ย Head of IP & Digital Law at Getinge, said:ย โ€œWith our extensive range of products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing, life science and digital healthcare solutions and our strong international presence with operations in more than 40 countries worldwide, it was important to be able to improve the efficiency and coordination of our IP management by consolidating onto a centralized platform. AQX enables us to do that, while also providing highly integrated functionality in key areas such as analytics and invention management.โ€

Bob Romeo, CEO of Anaqua, said:ย โ€œGetinge focuses on helping its customers save lives through the products and solutions it develops, and on achieving its goal of becoming the worldโ€™s most trusted and respected medtech company. We are delighted to be supporting Getinge on that journey by helping manage and protect the companyโ€™s valuable IP assets. Anaqua continues to invest in offerings to meet and exceed the ever-evolving demands of the worldโ€™s most innovative life science companies.โ€

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

AI-Driven Cold Chains Transforming Pharma Supply Systems

The integration of artificial intelligence into cold chain management is reshaping the pharmaceutical supply landscape. AI-driven cold chains utilize predictive visibility and intelligent thermal control to optimize logistics operations across global networks. By anticipating risks and automating complex decisions, these systems ensure the integrity of temperature-sensitive medications, significantly enhancing the reliability and efficiency of pharmaceutical distribution on a global scale.

Cold Chain Intelligence Enhancing Pharma Logistics Safety

Global pharmaceutical logistics faces unprecedented challenges in maintaining product integrity during transit. Cold chain intelligence offers a sophisticated solution by integrating predictive monitoring and thermal assurance into a connected supply chain. This approach ensures that life-saving medications and vaccines reach their destination without compromising safety or efficacy, marking a significant evolution in healthcare distribution.

Digital Supply Networks Strengthening Pharma Delivery

The transition from traditional linear supply chains to integrated digital supply networks is revolutionizing how pharmaceutical products are delivered. By leveraging connected visibility and real-time analytics, these networks enhance the resilience of cold chain operations. This technological evolution ensures that healthcare systems can respond dynamically to shifts in demand while maintaining the highest standards of safety and efficiency for patient care.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป